13F Filings History of Pharmstandard International S.A.

Latest 13F report
Q3 2018 - 15 Nov 2018
Value $
$29,018,000
Signature - Title
Eriks Martinovskis - Director
Location
Luxembourg, Luxembourg
Summary
This page shows a list of all the recent 13F filings made by Pharmstandard International S.A.. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Pharmstandard International S.A. reported 6 stock holdings with total value $29,018,000 as of Q3 2018. Top holdings included ALNAQ, PTGX, NTGN, JNCE, and PRTO.

Notify me when Pharmstandard International S.A. files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q3 2018 6 $29,018,000 +$5,027,000 -$54,772 +$4,972,228 ALNAQ, PTGX, NTGN, JNCE, PRTO 13F-HR 15 Nov 2018, 15:43
Q2 2018 5 $24,889,000 $0 -$4,520,259 -$4,520,259 ALNAQ, PTGX, JNCE, PRTO, ARGS 13F-HR 14 Aug 2018, 16:12
Q1 2018 5 $39,580,000 $0 $0 $0 JNCE, ALNAQ, PTGX, PRTO, ARGS 13F-HR 15 May 2018, 17:11
Q4 2017 5 $42,476,000 +$10,435,000 $0 +$10,435,000 PTGX, ALNAQ, JNCE, PRTO 13F-HR 14 Feb 2018, 13:41
Q3 2017 4 $33,385,000 +$1,005,182 $0 +$1,005,182 PTGX, JNCE, PRTO, ARGS 13F-HR 02 Nov 2017, 19:23
Q2 2017 4 $26,983,000 $0 $0 $0 PTGX, JNCE, ARGS, PRTO 13F-HR 15 Aug 2017, 17:24
Q1 2017 4 $35,165,000 +$14,559,000 -$16,653 +$14,542,347 JNCE, PTGX, ARGS, PRTO Restatement 16 Aug 2017, 20:24
Q4 2016 3 $88,729,000 $0 $0 $0 ARGS, PTGX, PRTO 13F-HR 13 Feb 2017, 20:02